Details for New Drug Application (NDA): 205923
✉ Email this page to a colleague
The generic ingredient in CASPOFUNGIN ACETATE is caspofungin acetate. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the caspofungin acetate profile page.
Summary for 205923
Tradename: | CASPOFUNGIN ACETATE |
Applicant: | Xellia Pharms Aps |
Ingredient: | caspofungin acetate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;INTRAVENOUS | Strength | 50MG/VIAL | ||||
Approval Date: | Jul 2, 2018 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;INTRAVENOUS | Strength | 70MG/VIAL | ||||
Approval Date: | Jul 2, 2018 | TE: | RLD: | No |
Complete Access Available with Subscription